减肥降脂活性成分的研究

肥胖是一种慢性营养性疾病,本质是机体的能量代谢平衡发生紊乱,随着人们生活水平的提高和生活方式的改变,肥胖已经成为危害人类健康的第一大杀手。肥胖能诱发一系列慢性代谢疾病,如II型糖尿病、高血压、高血脂等。然而市场上化学减肥产品种类泛滥,副作用大,容易反弹,以及市场上对减肥药不可或缺的需求为天然减肥药、中草药等的迅猛发展提供了一定的平台。大部分天然减肥药,中草药减肥活性成分不明确,药理机制不清楚等,是其走向世界的瓶颈,故本文对天然产物、中草药减肥降脂活性成分的作用机理、分类以及分子水平研究动态作系统综述并对其快速发展提出建议。     

减肥降脂活性成分的研究

肥胖是一种慢性营养性疾病,本质是机体的能量代谢平衡发生紊乱,随着人们生活水平的提高和生活方式的改变,肥胖已经成为危害人类健康的第一大杀手。肥胖能诱发一系列慢性代谢疾病,如Ⅱ型糖尿病、高血压、高血脂等。然而市场上化学减肥产品种类泛滥,副作用大,容易反弹,以及市场上对减肥药不可或缺的需求为天然减肥药、中草药等的迅猛发展提供了一定的平台。大部分天然减肥药,中草药减肥活性成分不明确,药理机制不清楚等,是其走向世界的瓶颈,故本文对天然产物、中草药减肥降脂活性成分的作用机理、分类以及分子水平研究动态作系统综述并对其快速发展提出建议。     

普洱茶减肥、降脂机制的探讨

普洱茶(Pu-erh tea)产于云南省南部地区,具有悠久的发展历史和丰富的文化涵蕴,被认为具有减肥、降脂、降血糖、防止心脑血管疾病等代谢性疾病功效.近几年来在人、啮齿类和细胞水平的研究表明,普洱茶的确具有减肥、降脂功效,普洱茶中的茶色素、多糖、多酚和他汀类物质可能通过抑制脂肪合成、促进脂肪氧化分解而发挥其减肥、降脂功效.本文综述了目前关于普洱茶减肥、降脂的生物学功效、活性成分、以及作用机制的相关报道,同时探讨了该领域未来的一些研究方向.     

普洱茶减肥、降脂机制的探讨

普洱茶(Pu-erhtea)产于云南省南部地区,具有悠久的发展历史和丰富的文化涵蕴,被认为具有减肥、降脂、降血糖、防止心脑血管疾病等代谢性疾病功效。近几年来在人、啮齿类和细胞水平的研究表明,普洱茶的确具有减肥、降脂功效,普洱茶中的茶色素、多糖、多酚和他汀类物质可能通过抑制脂肪合成、促进脂肪氧化分解而发挥其减肥、降脂功效。本文综述了目前关于普洱茶减肥、降脂的生物学功效、活性成分、以及作用机制的相关报道,同时探讨了该领域未来的一些研究方向。     

壳聚糖抑制植物病害的研究进展

壳聚糖是一种用途十分广泛的具有生物活性的高分子化合物,本文论述了壳聚糖在抑制作物病害方面的作用。壳聚糖和为土壤改良防治土传病害、用作种衣制防治种传丰、用于果蔬保鲜控制收获后病害,还可作为植物生长调节剂、病害剂促进植物生长、诱导提高植物的广谱抗生。壳聚糖抑制植物病害具有多重机制。文章对壳聚糖等甲壳糖素衍生物在农业上的应用剪影进行了讨论。     

壳聚糖的结构及抗菌作用研究进展

综述了壳聚糖的结构特点、抗菌机理和抗菌特点,并简单介绍了应用方面的研究及存在的问题。     

壳聚糖及其衍生物抗菌性质的研究进展

壳聚糖对多种细菌、真菌具有广谱抗菌的功能,因此它被广泛地应用于广泛地用于口腔疾病、皮肤炎症、伤口感染、胃肠道疾病等各种疾病的治疗。本文综述了壳聚糖及其衍生物对常见的口腔致病菌、皮肤癣菌、伤口感染菌以及胃肠道疾病的致病菌的抗菌作用和壳聚糖及其衍生物的抗菌机理。     

双歧啤酒预防性减肥作用的实验研究

目的探讨双歧啤酒预防大鼠肥胖的作用及其对大鼠血脂、瘦素和胰岛素的影响。方法48只SD大鼠被随机分成双歧啤酒低剂量组[12．5ml／（kg·BW）]、中剂量组[25ml／（kg·BW）]、高剂量组[50ml／（kg·BW）]和市售啤酒组[25ml／（kg·BW）]、肥胖模型组以及基础组,进行预防性减肥实验,观察双歧啤酒在大鼠致肥过程中对大鼠的影响,测定指标包括大鼠体重、体脂、脂肪细胞直径、血脂水平和血瘦素、血胰岛素。结果实验结果显示,双歧啤酒各组除TCHO外的所有测定指标值都较肥胖组有明显好转,特别是腹膜下脂肪重量、TG和HDL水平都与正常组差异无显著性,低、中剂量组脂肪细胞直径也与正常组差异无显著性。市售啤酒组所有指标均与肥胖模型组差异无显著性。结论双歧啤酒能有效预防血TG的升高,有效预防啤酒肚的形成。对于预防体脂和体重的增加也有一定作用。     

血脂康与阿托伐他汀降脂作用的比较

目的 :比较血脂康与阿托伐他汀对高脂血症大鼠的降脂作用。方法 :4 0只Wistar大鼠 (雄性 ,16 0～ 180g)平均分成四组 :正常对照组、模型组、血脂康组、阿托伐他汀组 ,连续给药 2 8d。结果 :血脂康组和阿托伐他汀组与模型组相比 ,总胆固醇 (TC)、甘油三脂 (TG)和低密度脂蛋白胆固醇 (LDL—C)参数值下降明显 ,血脂康组依次下降 10 %、17%、13% ;阿托伐他汀组依次下降11%、33%、16 % ,经t检验 ,降低差异均显著 (P <0 0 5 )。结论 :血脂康与阿托伐他汀对高脂血症大鼠均有良好的降脂作用 ,阿托伐他汀降TG作用优于血脂康     

人参皂苷降脂作用的研究

为了测定西洋参总皂苷及单体皂苷是否有降脂活性,通过体外实验分别测定脂肪分解活性、小肠刷状缘膜小囊吸收脂肪酸、三油酸甘油酯油酸的释放率。结果表明,西洋参茎叶总皂苷在0．5g／L浓度时,对胰脂肪酶活性的抑制率为90％;人参皂苷Rc,Rb1,Rb2对胰脂肪酶活性均显示很强的抑制作用,在0．5g／L浓度时抑制率分别为100％,96％,97％。西洋参总皂苷和人参皂苷Rc,Rh,Rb2可以通过抑制胰脂肪酶活性起到降脂作用。     

Effect of weight loss on muscle lipid content in morbidly obese subjects

The purpose of this study was to test the hypothesis that weight loss results in a reduction in intramuscular lipid (IMCL) content that is concomitant with enhanced insulin action. Muscle biopsies were obtained from morbidly obese individuals [body mass index (BMI) 52.2 +/- 2.5 kg/m(2); n = 6] before and after gastric bypass surgery, an intervention that improves insulin action. With intervention, there was a 47% reduction (P < 0.01) in BMI and a 93% decrease in homeostasis model assessment, or HOMA (7.0 +/- 1.9 vs. 0.5 +/- 0.1). Histochemically determined IMCL content decreased (P < 0.05) by approximately 30%. In relation to fiber type, IMCL was significantly higher in type I vs. type II fibers. In both fiber types, there were reductions in IMCL and trends for muscle atrophy. Despite these two negating factors, the IMCL-to-fiber area ratio still decreased by approximately 44% with weight loss. In conclusion, despite differing initial levels and possible atrophy, weight loss appears to decrease IMCL deposition to a similar relative extent in type I and II muscle fibers. This reduction in intramuscular triglyceride may contribute to enhanced insulin action seen with weight loss.     

Low birth weight: effect on insulin sensitivity and lipid metabolism

The metabolic and cardiovascular complications associated with reduced fetal growth have been identified during the past 10 years. These complications that encompass cardiovascular diseases and insulin resistance syndrome consist of dyslipidemia, impaired glucose tolerance or type 2 diabetes and appear to result from the initial development of insulin resistance. The association of reduced fetal growth with the other parameters of the syndrome X appear less constant than with insulin resistance and the expression and/or the age of onset seem to depend on the degree of genetic predisposition of the population. Although the mechanisms underlying the development of the insulin resistance associated with reduced fetal growth remain unclear, some evidence argues in favor of a key role of the adipose tissue. Several hypotheses have been proposed over the past 10 years to understand this unexpected association. Each of them points to either a detrimental fetal environment or genetic susceptibilities or interactions between these two components as playing a critical role in this context. Although not confirmed, the hypothesis suggesting that this association could be the consequence of genetic/environmental interactions remains at the moment the most attractive.     

Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatment

Impaired NO-dependent vasodilation of resistance vessels is an early marker of an increased risk of atherosclerosis; utility of the examination of microcirculation, however, is far less established. We have therefore tested the hypothesis that hypercholesterolemia is associated with an impaired microvascular reactivity and that this defect is at least partially reversible by lipid-lowering treatment. Twenty-seven otherwise healthy patients with severe hypercholesterolemia (HLP) were examined at rest and then after 10 weeks of atorvastatin treatment (20 mg/day). Skin microvascular reactivity (MVR) was examined by laser-Doppler flowmetry. Baseline MVR values of the studied group were compared to healthy control subjects, HLP patients with coronary artery disease (CAD) and diabetic patients with and without diabetic retinopathy. MVR was normal in HLP subjects without CAD. On the contrary, MVR was impaired in HLP patients with CAD. There was no effect of atorvastatin on MVR, despite the profound reduction of serum lipids. MVR values did not correlate with cholesterol levels. In diabetic subjects, the MVR was substantially impaired only in patients with retinopathy. In the subjects without retinopathy, MVR was either normal (type I diabetes) or moderately impaired (type II diabetes). MVR was thus normal in HLP patients without manifest vascular disease and was not influenced by lipid lowering therapy. Impairment in the MVR was only evident in subjects with HLP and severe CAD. These results suggest that microcirculation is not involved in the early vascular dysfunction induced by HLP and that MVR rather reflects changes which appear later in the course of the atherosclerotic disease.     

Study of the interpolyelectrolyte reaction between chitosan and alginate: influence of alginate composition and chitosan molecular weight

The interpolyelectrolyte reaction between chitosan (CHI) and alginate (ALG) was followed by conductimetry and potentiometry. Five chitosan samples, all with almost the same degree of N-acetylation (DA approximately 0.20) and molecular weights ranging from 5 x 10(3) to 2.5 x 10(5) Da were used. The polyelectrolyte complex was formed using alginate samples with three different M/G values (0.44, 1.31 and 1.96). The composition of the complex, Z (Z = [CHI]/[ALG]) resulted 0.70 +/- 0.02, independently of the molecular weight of chitosan and the composition of the alginate used. The degree of complexation was 0.51 with no dependence on the alginate composition.     

Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise

Obesity is associated with a decrement in the ability of skeletal muscle to oxidize lipid. The purpose of this investigation was to determine whether clinical interventions (weight loss, exercise training) could reverse the impairment in fatty acid oxidation (FAO) evident in extremely obese individuals. FAO was assessed by incubating skeletal muscle homogenates with [1-(14)C]palmitate and measuring (14)CO(2) production. Weight loss was studied using both cross-sectional and longitudinal designs. Muscle FAO in extremely obese women who had lost weight (decrease in body mass of approximately 50 kg) was compared with extremely obese and lean individuals (BMI of 22.8 +/- 1.2, 50.7 +/- 3.9, and 36.5 +/- 3.5 kg/m(2) for lean, obese, and obese after weight loss, respectively). There was no difference in muscle FAO between the extremely obese and weight loss groups, and FAO was depressed (-45%; P < or = 0.05) compared with the lean subjects. Muscle FAO also did not change in extremely obese women (n = 8) before and 1 yr after a 55-kg weight loss. In contrast, 10 consecutive days of exercise training increased (P < or = 0.05) FAO in the skeletal muscle of lean (+1.7-fold), obese (+1.8-fold), and previously extremely obese subjects after weight loss (+2.6-fold). mRNA content for PDK4, CPT I, and PGC-1alpha corresponded with FAO in that there were no changes with weight loss and an increase with physical activity. These data indicate that a defect in the ability to oxidize lipid in skeletal muscle is evident with obesity, which is corrected with exercise training but persists after weight loss.     

Synthesis of methylated chitosan containing aromatic moieties: Chemoselectivity and effect on molecular weight

N-Arylated chitosans were synthesized via Schiff bases formed by the reaction between the primary amino group of chitosan with aromatic aldehydes followed by reduction of the Schiff base intermediates with sodium cyanoborohydride. Treatment of chitosan containing N,N-dimethylaminobenzyl and N-pyridylmethyl substituents with iodomethane under basic conditions led to quaternized N-(4-N,N-dimethylaminobenzyl) chitosan and quaternized N-(4-pyridylmethyl) chitosan. Methylation occurred at either N,N-dimethylaminobenzyl and N-pyridylmethyl groups before the residual primary amino groups of chitosan GlcN units were substituted. The total degree of quaternization of each chitosan varied depending on the extent of N-substitution (ES) and the sodium hydroxide concentration used in methylation. Increasing ES increased the total degree of quaternization but reduced attack at the GlcN units. N,N-dimethylation and N-methylation at the primary amino group of chitosan decreased at higher ES’s. Higher total degrees of quaternization and degrees of O-methylation resulted when higher concentrations of sodium hydroxide were used. The molecular weight of chitosan before and after methylation was determined by gel permeation chromatography under mild acidic condition. The methylation of the N,N-dimethylaminobenzyl derivative with iodomethane was accompanied by numerous backbone cleavages and a concomitant reduction in the molecular weight of the methylated product was observed. The antibacterial activity of water-soluble methylated chitosan derivatives was determined using Escherichia coli (Gram-negative) and Staphylococcus aureus (Gram-positive) bacteria; minimum inhibitory concentrations (MIC) of these derivatives ranged from 32 to 128 μg/mL. The presence of the N,N-dimethylaminobenzyl and N-pyridylmethyl substituents on chitosan backbone after methylation did not enhance the antibacterial activity against S. aureus. However, N-(4-N,N-dimethylaminobenzyl) chitosan with degree of quaternization at the aromatic substituent and the primary amino group of chitosan of 17% and 16–30%, respectively, exhibited a slightly increased antibacterial activity against E. coli.     

A combined healthy strategy for successful weight loss,weight maintenance and improvement of hepatic lipid metabolism

Obesity is critically related with the development of metabolic and pathophysiological alterations among which non-alcoholic fatty liver disease (NAFLD) is of especial relevance. Although there are numerous strategies to successfully treat obesity, the prevention of weight regain still remains challenging for individuals who have undergone weight loss programs. In such context, diet and physical activity are considered essential for the regulation of body weight and lipid metabolism. In this study, rats were fed a high-fat diet (HFD) to induce obesity and alterations in hepatic lipid metabolism. Obese rats were then treated with single or combined strategies of caloric restriction, physical exercise, and/or pharmacological treatment with an appetite suppressant, to lose weight, reverse the obesity-related alterations in hepatic morphology and lipid metabolism and maintain the beneficial effects of the interventions used. HFD induced excess body weight, hepatic steatosis, altered fatty acid profile, dysregulated gene expression of lipogenic and lipolytic enzymes, as well as plasma markers of liver damage, and modifications in liver antioxidant enzyme activity. Such alterations were ameliorated by caloric restriction in combination with a mixed training protocol and/or food-intake inhibitor administration during a weight loss intervention period of 3 weeks, and the beneficial effects remained after 6 weeks of weight maintenance, with some interesting interactions observed. In conclusion, weight loss strategies assayed were efficient at correcting the obesogenic action of a HFD and related alterations in hepatic functionality through different molecular mechanisms. The beneficial effects were also evident along the post-intervention maintenance period to avoid body weight regain.     

Responses of adipose tissue lipoprotein lipase to weight loss affect lipid levels and weight regain in women

This study determines whether changes in abdominal (ABD) and gluteal (GLT) adipose tissue lipoprotein lipase (LPL) activity in response to a 6-mo weight loss intervention, comprised of a hypocaloric diet and low-intensity walking, affect changes in body composition, fat distribution, lipid metabolism, and the magnitude of weight regain in 36 obese postmenopausal women. Average adipose tissue LPL activity did not change with an average 5.6-kg weight loss, but changes in LPL activity were inversely related to baseline LPL activity (ABD: r = -0.60, GLT: r = -0.48; P < 0.01). The loss of abdominal body fat and decreases in total and low-density lipoprotein cholesterol were greater in women whose adipose tissue LPL activity decreased with weight loss despite a similar loss of total body weight and fat mass. Moreover, weight regain after a 6-mo follow-up was less in women whose adipose tissue LPL activity decreased than in women whose LPL increased (ABD: 0.9 +/- 0.5 vs. 2.8 +/- 0.6 kg, P < 0.05; GLT: 0.2 +/- 0.5 vs. 2.8 +/- 0.5 kg, P < 0.01). These results suggest that a reduction in adipose tissue LPL activity with weight loss is associated with improvements in lipid metabolic risk factors with weight loss and with diminished weight regain in postmenopausal women.     

Effect of lipid lowering tablet on blood lipid in hyperlipidemia model rats

Observe the effect of lipid-lowering tablets on body weight, liver index and serum biochemical indexes of hyperlipidemia rats. The hyperlipidemia rat model was replicated successfully. Compared with the model group, high, medium and low dose lipid-lowering tablets group could significantly increase the body weight of rats with hyperlipidemia (P?<?0.01, P?<?0.05); High and middle dose lipid-lowering tablets group could significantly reduce the liver index of high fat rat (P?<?0.01); High, medium and low dose lipid-lowering tablets group could significantly decrease levels of TC, TG, LDL-C, AST, ALT, ALP, Y-GT in serum (P?<?0.01, P?<?0.05), and significantly increase the level of HDL-C (P?<?0.01). Lipid-lowering tablets can effectively regulate the body lipid metabolism of rats, and have a certain therapeutic effect on hyperlipidemia.     

不同分子量壳聚糖对土壤碳、氮及呼吸的影响

考察了不同分子量壳聚糖对土壤微生物量C、N、土壤呼吸及矿质N的影响.研究发现：不同分子量的壳聚糖施入土壤后,土壤的微生物量C、N、呼吸及矿质N均明显提高.微生物量C、N及土壤呼吸有相似的变化趋势： 随壳聚糖用量的增加而增大.低分子量壳聚糖施入土壤后,微生物量C、N及土壤呼吸均先快速增加,然后下降;中等及高分子量壳聚糖施入土壤后则是开始时变化较小,第14天开始快速增加,34d后下降.研究还发现,NO3^--N与NH4^＋-N变化趋势不完全相同,NO3^--N开始时变化较小,第14天开始快速增加,34d后快速下降;低分子量壳聚糖处理时,NH4^＋-N开始时快速增加,之后缓慢下降;中等分子量壳聚糖处理时,因加入量不同而不同;高分子量壳聚糖处理时则是从第24天开始变化显著.